Procurement Summary
Country : USA
Summary : Extracellular Rna Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (Amppd) (R24 - Clinical Trial not Allowed)
Deadline : 19 Sep 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 68761825
Document Ref. No. : RFA-NS-23-014
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)
CFDA Number : 93.279 -- Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Sep 19, 2022
Posted Date : Jul 08, 2022
Description: This funding opportunity announcement (FOA) seeks applicants experienced in the isolation and sequencing of RNA from brain-derived extracellular vesicles to develop a research resource for the Accelerating Medicines Partnership in Parkinson's Disease (AMP PD). Approximately 2400 blood samples will be provided for this project from existing Parkinson's disease and normal control cohorts that already have longitudinal clinical and sequencing data that is publicly available to interested researchers. It is intended that this resource will become a part of the AMP PD Knowledge Platform, where it will be broadly shared with the research community.
Documents
Tender Notice